2012
The Use of Molecular Breast Imaging to Assess Response in Women Undergoing Neoadjuvant Therapy for Breast Cancer
Wahner-Roedler DL, Boughey JC, Hruska CB, Chen B, Rhodes DJ, Tortorelli CL, Maxwell RW, S. S, O'Connor MK. The Use of Molecular Breast Imaging to Assess Response in Women Undergoing Neoadjuvant Therapy for Breast Cancer. Clinical Nuclear Medicine 2012, 37: 344-350. PMID: 22391702, PMCID: PMC3296091, DOI: 10.1097/rlu.0b013e31824437b3.Peer-Reviewed Original ResearchConceptsMolecular breast imagingNeoadjuvant therapyTumor sizeBreast cancerResidual tumor sizeProspective pilot studyInvasive breast cancerBreast cancer treatmentTumor-specific radiopharmaceuticalsPathologic extentResidual diseasePretreatment valuesTumor responseTumor extentPosttreatment valuesIntravenous injectionPathologic measurementsRadiotracer uptakePredictive valueMolecular breastPatientsCancerCancer treatmentPilot studyInterest analysis
2010
Vulvovaginal Atrophy
Bride M, Rhodes DJ, Shuster LT. Vulvovaginal Atrophy. Mayo Clinic Proceedings 2010, 85: 87-94. PMID: 20042564, PMCID: PMC2800285, DOI: 10.4065/mcp.2009.0413.Peer-Reviewed Original ResearchConceptsVulvovaginal atrophyLocal estrogen treatmentBreast cancer treatmentGroup of womenWoman's life cycleSystemic estrogenUrinary frequencyPostmenopausal phaseVVA symptomsClinical findingsVaginal pHEstrogen treatmentUnderreported conditionVaginal wallVulvovaginal mucosaVaginal tissueChemotherapeutic agentsVaginal rugaeCancer treatmentAtrophySymptomsPrevalenceTreatmentWomenDyspareunia